David Annis
Chief Tech/Sci/R&D Officer presso AILERON THERAPEUTICS, INC.
Patrimonio netto: 2 500 $ in data 31/03/2024
Profilo
David Allen Annis is currently the Senior Vice President-Research at Aileron Therapeutics, Inc. He previously worked as the Director-Technology Development at Schering-Plough Research Institute and as the Vice President-New Technologies at NeoGenesis Pharmaceuticals, Inc. Dr. Annis received his graduate and doctorate degrees from Harvard University and his undergraduate degree from Georgia Institute of Technology.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 30/11/2023 | 377 ( 0.01% ) | 2 500 $ | 31/03/2024 |
Posizioni attive di David Annis
| Società | Posizione | Inizio |
|---|---|---|
| AILERON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 05/11/2018 |
Precedenti posizioni note di David Annis
| Società | Posizione | Fine |
|---|---|---|
NeoGenesis Pharmaceuticals, Inc.
 NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeoGenesis Pharmaceuticals, Inc. used to discover and develop small molecule drugs. The company was founded in 1997 by Allen H. Michels and was headquartered in Cambridge, MA | Corporate Officer/Principal | - |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | - |
Formazione di David Annis
| Harvard University | Doctorate Degree |
| Georgia Institute of Technology | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AILERON THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
NeoGenesis Pharmaceuticals, Inc.
NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeoGenesis Pharmaceuticals, Inc. used to discover and develop small molecule drugs. The company was founded in 1997 by Allen H. Michels and was headquartered in Cambridge, MA | Health Technology |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Health Technology |
- Borsa valori
- Insiders
- David Annis
